U of A PhD candidate studies and participates in grassroots movement to hack diabetes equipment. People with Type 1 diabetes—including U of A graduate student Jonathan Garfinkel—are using free instructions from the internet to build an artificial pancreas. The patient-led movement is pushing pharmaceutical companies to improve the treatments they offer, according to U of...
Tag: <span>diabetic</span>
Post
Century-old drug repurposed to fight diabetic foot ulcers
by Marcene Robinson, University at Buffalo Suramin, a 100-year old drug used to treat sleeping sickness, has been repurposed to fight oral mucositis and diabetic foot ulcers, according to University at Buffalo-supported research. The breakthrough, led by researchers at the University of Arizona with the support of Keith Kirkwood, DDS, Ph.D., Centennial Endowed Chair and...
Post
Smart contact lenses that diagnose and treat diabetes
CREDIT: SEI KWANG HAHN (POSTECH) Diabetes is called an incurable disease because once it develops, it does not disappear regardless of treatment in modern medicine. Having diabetes means a life-long obligation of insulin shots and monitoring of blood glucose levels. But what if you could control the secretion of insulin just by wearing contact lenses?...
Post
In US, diabetics turn to black market or Canada for life-saving insulin
On a frosty January morning in a Minneapolis suburb, Abigail Hansmeyer leaves her car engine running and takes out a brown paper bag carrying needles and a vial, handing it over to its recipient in an anonymous shopping center parking lot. The exchange is technically illegal, but these aren’t illicit drugs. Instead, the vial contains...
Post
It’s not just insulin: Diabetes patients struggle to get crucial supplies
by Bram Sable-Smith In the first three months after getting his Dexcom continuous glucose monitor, Ric Peralta said, he reduced his average blood sugar level by 3 percentage points. “It took me from not-very-well-managed blood sugar to something that was incredibly well managed,” said Peralta, a 46-year-old optician in Whittier, Calif., who was diagnosed with...
Post
Earlier detection of diabetic retinopathy with smartphone AI
by Shelley Zalewski, University of Michigan A novel pairing of two technologies may offer a solution for better screening for diabetic retinopathy, a condition that can lead to permanent vision loss if not caught early. At the 2019 annual meeting of the Association for Research in Vision and Ophthalmology, researchers at the University of Michigan Kellogg Eye Center...
Post
A better strategy for treating diabetic macular edema in people with good vision
Close monitoring appears to provide results equal to immediate treatment with lower cost and lower risk JOSLIN DIABETES CENTER BOSTON – (April 29, 2019) – A change to the approach for treating diabetic macular edema may be on the way, thanks to a study published today in the Journal of the American Medical Association. The...
Post
Experimental drug delivers one-two punch to vision loss
by Johns Hopkins University School of Medicine In studies with lab-grown human cells and in mice, Johns Hopkins Medicine researchers have found that an experimentaldrug may be twice as good at fighting vision loss as previously thought. The new research shows that the compound, named AXT107, stops abnormal blood vessels in the eye from leaking vision-blocking fluids. These results build on previous research that...
Post
Statin therapy reduces risk for diabetic retinopathy in T2DM
(HealthDay)—For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, according to a study published online Jan. 10 in JAMA Ophthalmology. Eugene Yu-Chuan Kang, M.D., from the Chang Gung Memorial Hospital in Taoyuan, Taiwan, and colleagues examined the correlation between statin therapy and development of...
Post
Human clinical trial reveals verapamil as an effective type 1 diabetes therapy
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by type 1 diabetes UNIVERSITY OF ALABAMA AT BIRMINGHAM BIRMINGHAM, Ala. – Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce...